Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

189

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N06AX16	VENLAX XR 37.5	G	Venlafaxine - 37.5mg	37.5mg	Capsule, extended release	575,933 L.L
C01BC04	FLECAINIDE BIOGARAN L.P.	G	Flecainide acetate - 100mg	100mg	Capsule, extended release	1,154,361 L.L
C01BC04	FLECAINIDE BIOGARAN L.P.	G	Flecainide acetate - 50mg	50mg	Capsule, extended release	1,154,361 L.L
A02BC05	ESOMEPRAZOLE ARROW LAB	G	Esomeprazole - 20mg	20mg	Capsule, gastro-resistant	366,869 L.L
A02BC05	ESOMEPRAZOLE BIOGARAN	G	Esomeprazole (magnesium dihydrate) - 20mg	20mg	Capsule, gastro-resistant	493,190 L.L
A02BC05	PRIMAZOL 20	G	Esomeprazole (magnesium dihydrate) - 20mg	20mg	Capsule, gastro-resistant	511,940 L.L
A02BC05	ESOMEPRAZOLE ARROW LAB	G	Esomeprazole - 40mg	40mg	Capsule, gastro-resistant	454,219 L.L
A02BC05	ESOMEPRAZOLE BIOGARAN	G	Esomeprazole (magnesium dihydrate) - 40mg	40mg	Capsule, gastro-resistant	513,348 L.L
A02BC05	PRIMAZOL 40	G	Esomeprazole (magnesium dihydrate) - 40mg	40mg	Capsule, gastro-resistant	639,925 L.L
N06AX21	DULOXETINE BIOGARAN	G	Duloxetine HCl - 60mg	60mg	Capsule, gastro-resistant	573,821 L.L
N06AX21	DULOXETINE BIOGARAN	G	Duloxetine HCl - 30mg	30mg	Capsule, gastro-resistant	573,821 L.L
L04AX04	LENALIDOMIDE SPC	G	Lenalidomide - 25mg	25mg	Capsule, hard	87,161,381 L.L
L04AX04	LENOMA	G	Lenalidomide - 25mg	25mg	Capsule, hard	15,343,847 L.L
L01XX05	UNIDREA	G	Hydroxycarbamide (or Hydroxyurea) - 500mg	500mg	Capsule, hard	2,539,862 L.L
L04AX06	IMNOVID	B	Pomalidomide - 2mg	2mg	Capsule, hard	290,515,206 L.L
L04AX06	IMNOVID	B	Pomalidomide - 4mg	4mg	Capsule, hard	290,515,206 L.L
L01EA01	SAGITTA	G	Imatinib - 400mg	400mg	Capsule, hard	51,723,840 L.L
C09BB07	RAMIPRIL/AMLODIPINE GENERICON	G	Ramipril - 2.5mg, Amlodipine - 5mg		Capsule, hard	1,358,625 L.L
C09BB07	RAMIPRIL/AMLODIPINE GENERICON	G	Ramipril - 5mg, Amlodipine - 5mg		Capsule, hard	1,358,625 L.L
C09BB07	RAMIPRIL/AMLODIPINE GENERICON	G	Ramipril - 10mg, Amlodipine - 5mg		Capsule, hard	1,358,625 L.L
L01EA01	SAGITTA	G	Imatinib - 100mg	100mg	Capsule, hard	25,170,264 L.L
C09BB07	RAMIPRIL/AMLODIPINE GENERICON	G	Ramipril - 10mg, Amlodipine - 10mg		Capsule, hard	1,358,625 L.L
L01AX03	TEMOZOLOMIDE ACCORD	G	Temozolomide - 20mg	20mg	Capsule, hard	L.L
A07AX03	NIFUNAL	G	Nifuroxazide - 200mg	200mg	Capsule, hard	217,702 L.L
N05AX15	REAGILA	G	Cariprazine HCl - 1.5mg	1.5mg	Capsule, hard	6,394,003 L.L
L01EA03	NILORA	G	Nilotinib - 200mg	200mg	Capsule, hard	122,185,399 L.L
N05AX15	REAGILA	G	Cariprazine HCl - 3mg	3mg	Capsule, hard	6,394,003 L.L
N05AX15	REAGILA	G	Cariprazine HCl - 4.5mg	4.5mg	Capsule, hard	6,394,003 L.L
N05AX15	REAGILA	G	Cariprazine - 6mg	6mg	Capsule, hard	6,394,003 L.L
L01EC03	BRAFTOVI	BioTech	Encorafenib - 50mg	50mg	Capsule, hard	70,084,833 L.L

...

189